CARsgen Therapeutics Holdings Ltd Sustainability Reports
CARsgen Therapeutics Holdings Limited is a clinical-stage biopharmaceutical company focused on discovering, researching, and developing innovative CAR T-cell therapies. The company develops treatments targeting hematologic malignancies, solid tumors, and autoimmune diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG011BNS4G7
5 reports from 2021 to 2025
